Bersanelli M, Buti S. Cabozantinib in renal cell carcinoma: only a METEOR or a rising star?. Acta Biomed [Internet]. 2016 Sep. 13 [cited 2022 Jun. 30];87(2):224-5. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/5151
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.